HTGF Exit PreOmics | HTGF (2023)

January 18, 2022

PreOmics Offers Unique Technologies, Advanced Automation Solutions and High-Performance Consumables for the Homogenization, Enrichment and Proteomic Sample Preparation of Biopsy, Tissue, Cell Line and Plasma Samples in Unbiased, Deep Proteomics for Pharmaceutical and Clinical Research

MUNICH, Germany – January 18, 2022 – PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, has raised €13.5m in a Series B financing round provided by Bruker Corporation (Nasdaq: BRKR). PreOmics was founded in 2016 by Dr. Garwin Pichler and Dr. Nils A. Kulak as a spin-out company from the laboratory of leading proteomics researcher Professor Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried

In conjunction with the Series B primary financing, several early investors in PreOmics, such as High-Tech Gründerfonds (HTGF) and Think.Health Ventures, as well as certain business angels, have successfully sold their PreOmics shares to Bruker in a parallel secondary transaction, and Bruker is now a majority investor in PreOmics. Financial details of the secondary transactions were not disclosed.

PreOmics’ innovative sample processing technologies for mass spectrometry-based protein analysis are complementary to Bruker’s high-performance scientific instruments, as well as to proteomics mass spectrometry systems by other leading proteomics companies. Close workflow collaboration synergies are expected to broaden the market opportunities for both PreOmics’ BeatBox platform technologies and Bruker’s timsTOF 4D proteomics platform with more complete, automated workflow solutions for academic and clinical researchers, for biomarker discovery and diagnostics companies, as well as for CRO and biopharmaceutical companies.

We are excited to increase R&D, marketing and sales investments, and are pleased to have Bruker as a collaborator and major investor. Bruker shares our vision for advanced proteomic discovery processes for everyone, and a commitment to accelerate PreOmics’ growth. Our existing and future customers and partners will benefit from accelerated investments at PreOmics and from proteomics solution synergies to extend or product offerings and global presence.

Dr. Garwin Pichler, Co-Founder and Managing Director of PreOmics

We see a bright future for PreOmics’ research, development and commercialization efforts accelerated by the Series B primary investments and Bruker as partner and scientific collaborator. Our novel BeatBoxtechnology is seamlessly compatible with PreOmics’ proteomic sample preparation technologies and in combination with thetimsTOF Proprovides end-to-end workflows for processing of large tissue biobanks. Furthermore, we aim to develop integrated and automated BeatBox-based workflow solutions for every experience level and throughput need, while providing highest performance levels for unbiased, deep and comprehensive proteomics research.

Dr. Nils A. Kulak, Co-Founder and Managing Director of PreOmics

(Video) Spider-Man Pranked By Thor | No Way Home

The fact that our time as a seed investor in Preomics has come to an end already after 5 years is a proof for the fantastic performance of both the management and the extremely innovative technology. Thank you Garwin and Nils for having let us be a part of your journey. Joining forces with your partner Bruker Inc. now paves the way for setting gold standards in protein preparation and will thus make proteome analysis easier and more reliable than ever.

Dr. Bernd Goergen, Partner at High-Tech Gründerfonds

Think.Health is grateful for having shared an important part of PreOmics’ success story, which will continue also beyond our investment with the great support by Bruker. We appreciate Garwin and Nils as exceptional scientists and visionary entrepreneurs – a rare combination we definitely need more of in Germany.

Dr. Michael Ruoff of Think.Health Ventures

We are very pleased to invest in PreOmics, a leading proteomics sample preparation, automation and consumables company, with this Series B primary financing. By also acquiring a majority investment in PreOmics, Bruker further expands its proteomics vision to include the unique PreOmics sample preparation technologies, as well as more comprehensive, automated, robust and reproducible workflows and consumables for translational, biomarker and biopharma proteomics research.

Dr. Frank H. Laukien, President and CEO of Bruker Corporation

About PreOmics GmbH
PreOmics empowers our clients in life sciences to establish biological knowledge through efficient, reliable solutions and workflows that set the standard for protein analysis. Our team spirit, energy, and commitment empower us to be both creative and quality focused – A trusted partner with deeply rooted scientific experience. We envisage a future with revolutionary proteomic discovery processes open for everyone. Tools that reveal hidden causes of diseases, ensure sustainable nutrition, and provide diagnoses that enhance lives and society.

For more information, contact:
Dr. Garwin Pichler, Founder & Managing Director
PreOmics GmbH
Phone: +49 (0) 89 / 23 14 163 – 0
Address: Am Klopferspitz 19 | 82152 Planegg/Martinsried | Germany

About Think.Health Ventures
Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek for innovations and disruptive business models in digital healthcare, life sciences, pharmaceuticals and biotechnology. For more information please visit

(Video) Junya1gou funny video 😂😂😂

About High-Tech Gründerfonds
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups. With around EUR 900 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 650 start-ups since 2005. Driven by their expertise, entrepreneurial spirit and passion, its team of experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial technology, life sciences, chemistry and related business areas. To date, external investors have injected more than EUR 3.5 billion into the HTGF portfolio via more than 1,800 follow-on financing rounds. HTGF has also successfully sold interests in more than 150 companies.
Investors in this public-private partnership include the Federal Ministry for Economic Affairs and Climate Action, KfW Capital, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Bank, Deutsche Post DHL, Dräger, 1+1 AG, EVONIK, EWE AG, FOND OF, Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Media Contact
High-Tech Gründerfonds Management GmbH
Stefanie Grüter, Head of Marketing & Communications
T.: +49 228 – 82300 – 188

Investor Contact
High-Tech Gründerfonds Management GmbH
Dr. Bernd Goergen, Partner
T.: +49 228 – 82300 – 136

Dr. Fabian Mohr –Senior Investment Manager Dr. Bernd Goergen –Partner

HTGF Exit PreOmics | HTGF (1)

Stay up to date

Subscribe now and receive the latest press releases on investments and other news from High-Tech Gründerfonds.We inform you about important developments at HTGF and provide you with interesting news from our portfolio. Whether it’s a successful exit, a new exciting investment or HR news – you’ll be the first to know!

Subscribe to our press releases

(Video) Scary Teacher 3D Siren Head vs Among Us Mods Hulk Test Game Strong Arm Champion Nick Hulk and Miss T

More Press posts


14. March 2023

HTGF's 700th seed investment: Munich-based start-up oculai completes €2.5million seed round to drive AI-based process monitoring on construction sites

ConTech start-up oculai secures €2.5million during seed financing roundThe financing round was led by High-Tech Gründerfonds (HTGF), with Bayern Kapital, Axeleo Capital, and other renowned private investors and an accelerator program also taking partThis is the 700th seed investment of High-Tech Gründerfondsoculai is a technology for automated process and progress monitoring for construction sitesMunich, 14 March 2023- oculai has secured €2.5millio

(Video) High-Tech Gründerfonds HTGF


8. March 2023

The Swiss startup AICA closes CHF 1.2 million financing round, to give robots a sense of touch and enable autonomous learning

AICA SA receives CHF 1.2 million in Seed round from Spicehaus Partners, High-Tech Gründerfonds, and Schaeffler Group.The Swiss startup uses Artificial Intelligence to automate manufacturing processes that are complex and hard for people to accomplish.The raised funds will allow the EPFL spin-off to expand its library of applications and deploy its solutions internationally.Lausanne, Switzerland, 8 March 2023 - The Lausanne-based EPFL-Spin Off from the LASA, which aims to m


(Video) Subway Surfers Gameplay PC HD

2. March 2023

Toolify secures seed funding from HTGF to make robotics more accessible for SMEs

Toolify's XITO is a one-stop shop for individual automation solutions using robots, designed specifically for small and medium-sized enterprises.The holistic solution enables companies to quickly, easily, and cost-effectively initiate robot-assisted automation of manual tasks.The raised capital from the seed round with High-Tech Gründerfonds will be used to enhance product development and expand sales activities.Ulm, 2 March 2023 –The Ulm-based start-up Toolify, founded


1. HTGF Investors Perspective on Big Data and AI
2. How To Get Free Items By Using Htgf
(Noorya On Stardoll)
3. automatic HTGF-100 pharmaceutical tube filling sealing machine
(Christine Yuan)
4. HTGF 100 aluminum tube filling folding machine
(Chinese packing machine)
6. Raising funds from the German VC: hands-on tips for expat founders!
(Expat Ventures in Germany)
Top Articles
Latest Posts
Article information

Author: Prof. An Powlowski

Last Updated: 04/11/2023

Views: 5708

Rating: 4.3 / 5 (44 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Prof. An Powlowski

Birthday: 1992-09-29

Address: Apt. 994 8891 Orval Hill, Brittnyburgh, AZ 41023-0398

Phone: +26417467956738

Job: District Marketing Strategist

Hobby: Embroidery, Bodybuilding, Motor sports, Amateur radio, Wood carving, Whittling, Air sports

Introduction: My name is Prof. An Powlowski, I am a charming, helpful, attractive, good, graceful, thoughtful, vast person who loves writing and wants to share my knowledge and understanding with you.